Home/Rare Diseases/Wilson Disease
Metabolic & Lysosomal

Wilson Disease

Affects approximately
1 in 30,000 people worldwide

Also known as: Wilson's disease, hepatolenticular degeneration

Wilson Disease

About Wilson Disease

Wilson disease is a rare genetic disorder affecting copper metabolism, caused by mutations in the ATP7B gene that encodes a copper-transporting protein. In normal physiology, excess copper is excreted through bile, but in Wilson disease, copper accumulates progressively in the liver, central nervous system, and other organs, causing severe damage if untreated. The disease can present with acute liver failure, progressive neurological disease (including tremor, dystonia, and parkinsonism), or psychiatric manifestations. Many patients also develop distinctive greenish-brown rings on the cornea, called Kayser-Fleischer rings, which are diagnostic. Early diagnosis and treatment are critical; patients treated before symptom onset or in early stages can have near-normal lifespans and quality of life. Treatment involves lifelong copper chelation therapy or zinc supplementation to reduce copper levels and prevent further accumulation.

Common Symptoms

  • Kayser-Fleischer rings (greenish rings around the iris)
  • Progressive liver damage and jaundice
  • Tremor, rigidity, and movement problems
  • Psychiatric symptoms and mood changes
  • Speech and swallowing difficulties
  • Abdominal pain and hepatitis

Who It Affects

Usually manifests in childhood or young adults (ages 6-45). Affects males and females equally. Has higher prevalence in certain ethnic populations including Ashkenazi Jews, Southern Europeans, and East Asians.

Getting Involved in Clinical Trials

Clinical trials for Wilson disease are evaluating new copper-chelating agents, zinc formulations, and gene therapy approaches. The Wilson Disease Association maintains a registry and provides current trial information and connects patients with specialists experienced in Wilson disease management. Check ClinicalTrials.gov for ongoing studies in your region. Because early diagnosis and treatment are so critical, if you have a family member with Wilson disease, genetic testing and screening should be discussed even before symptoms develop. Genetic counselors and hepatologists specializing in metabolic liver disease can help determine trial eligibility.

Trusted Sources

Active Clinical Trials for Wilson Disease

Finding trials for Wilson Disease...

Related Metabolic & Lysosomal Conditions

Metabolic & Lysosomal

Phenylketonuria

Phenylketonuria is an inherited metabolic disorder caused by a missing enzyme that prevents the body from properly break...

Metabolic & Lysosomal

Fabry Disease

Fabry disease is a rare inherited lysosomal storage disorder where a missing enzyme causes fatty substances called globo...

Metabolic & Lysosomal

Pompe Disease

Pompe disease is a rare inherited lysosomal storage disorder caused by deficiency of the enzyme acid alpha-glucosidase, ...